SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Art Baer who wrote (624)4/9/1997 1:51:00 AM
From: William Presti   of 1172
 
Did anyone else notice that there might be TWO HIV tests in Chemtrak's future? Maybe I'm just not understanding this correctly, but according to Chemtrak's website the AWARE test kit requires one to place three drops of blood on a treated card and then send the card to Chemtrak's lab for analysis. Then there is this exerpt from the 19 March 1997 press release: "...Gunupudi, who has been instrumental in the development of ChemTrak's H.pylori test, will lead the ongoing
development of several new products including the company's new one-step AccuMeter HIV test." Correct me if I'm wrong, but this is the first I have read of Chemtrak working the HIV test into their patented Accumeter technology. This would seem like as great development if it is so. Comments?

Also, about the number of CMTR shareholders... According to Ed Covell himself, there are approximately 5000 of us. What is that 600 figure all about? A misprint?

Lastly, the money that CMTR will probably need is IMO for the upcoming rollout of AWARE. That's what the 5 mill was supposed to be for last year, but approval never came.

Good night, all.

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext